BTG1 and hepatocellular carcinoma: The studies in gastric and hepatocellular carcinoma found no evidence for promoter hypermethylation or gene mutations as the causative factor for BTG1 downregulation (Kanda, Oya, et al., 2015; Kanda, Sugimoto, et al., 2015).